Skip to content
TrustList
Broadline Capital cover

About Broadline Capital

  • Next, we take a "Bottom-Up" view to selectively identify category leaders and category creators that focus on a large addressable market where Broadline has access to relevant domain expertise
  • We place emphasis on companies that are projected to be nearing a liquidity event such as an IPO and have a management team in place with the capability to capture the full opportunity

We place emphasis on 5 Thematic Areas of Focus:

  • Electrification of Everything
  • Batteries, Electric Powertrains, and Charging Infrastructure enabling the "Electrification of Everything" from Industrial Equipment to Commercial Trucks, Aircraft, and Watercraft
  • Purpose-driven Technologies
  • Creative business models that provide broad access to unprecedented efficiencies through AI, SaaS, Robotics, Business Process Automation, 5G WiFi, and Low Earth Orbit (LEO) Satellites
  • Financial Services
  • FinTech and DeFi solutions that unlock value through digital products and services that are Smarter, Faster, and More Accessible
  • Healthcare
  • Innovative platforms based on AI, SynBio, and non-invasive devices that show promising potential for improved patient safety and clinical outcomes
  • Food System
  • Agritech, Smart Vertical Greenhouse Technologies, and delivery solutions that improve Food Safety, Traceability, Production Efficiency, and Supply Chain Resilience

We invite you to scroll through case examples below If you are a Broadline registered investor, please click on the "Investor Login" tab at the top of this website for recent management reports from current portfolio companies

EndoSphere is a medical technology company that has developed a first-in-class, less-invasive medical device platform to treat metabolic diseases, including some of the world's largest healthcare issues such as Obesity, Type 2 Diabetes, and Fatty Liver Disease EndoSphere's novel "Endo-Metabolic" device platform represents a completely new category of devices that is the first to uniquely focus on the Duodenum, the upper intestinal organ that is widely recognized as the body's metabolic control center Endosphere's flagship anti-obesity device is incisionless, reversible and repeatable In clinical studies, the device enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for more invasive alternatives Unlike restrictive devices and bariatric surgeries, which typically work against nature, EndoSphere's "Endo-Metabolic" devices work with the body by amplifying its physiological responses to food intake in order to help accelerate satiation, recalibrate brain-gut metabolic feedback loops, recalibrate hormones, and rebalance insulin levels EndoSphere's patent asset portfolio is 100% company-owned and free from any third-party licensing or royalty obligations EndoSphere has received numerous industry recognitions, including the industry's "Fierce15" award, named by FierceBiotech, which annually recognizes the world's most promising privately-held medical innovations ​​ The original version of its anti-obesity device received CE Mark (regulatory approval in 31 countries), and an enhanced version has entered clinical stages of development For more information, visit https://www endo-sphere com

Carbon-Free Lithium-ion and Solid State BatterY CATHODES Powermers has created the world's first Carbon-Free Cathodes for lithium-ion and solid state batteries They did it by replacing "inactive/deadweight" material (carbon, binders and solvents) with proprietary conductive polymers Powermers' transition-metal polymers demonstrate higher catalytic functionality than pure noble-metal catalysts (including gold, platinum, and palladium) Their differentiated results in Safety and Energy Capacity are documented in industry peer-review publications including American Chemical Society's Applied Materials & Interfaces 5 measurable advantages have been Independently validated by U S Army Corps of Engineers (CERL) and universities around the world including the Center for Automotive Research at The Ohio State University (O S U C A R ) For more information, please visit https://www powermers com

  • Safer:  Our simplified cathode increases Safety and Stability by reducing Thermal Runaway Risk (cause of most high-voltage lithium-ion battery combustion)

  • Less Toxic: Reduces reliance on Toxic Solvents

- Higher Energy: Expands the Active Material Limit, increasing Energy without sacrificing Power, Cycle Life, Weight, or Cost per KWH

  • Drop-in Replacement:  Enables ease of adoption into established battery manufacturing processes

  • Reduced Cost per KWH:  Total Cost per KWH is also enabled by the decreased reliance on costly toxic solvents

"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are working to transform their ideas into the next big, industry-changing company " If you share our perspective, we invite you to join us

We look forward to hearing from you

80 SW 8th St , 20th Floor Broadline® is a Registered Trademark

Copyright © Broadline Capital LLC 2005-2023

Ask TrustList to introduce you to Broadline Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Broadline Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Broadline Capital.

Broadline Capital alternatives

Similar listings buyers compare against this one.